Oxidative Stress in Rat Retina and Hippocampus after Chronic MDMA (‘ecstasy’) Administration

Saunders N (1995) In: Ecstasy and the dance culture. Nicholas Saunders, London Robbins TW, Everitt BJ (1999) Drug addiction: bad habits add up. Nature 398:567–570 Reneman L (2003) Designer drugs: how dangerous are they? J Neural Transm 66:61–83 Schmidt CJ (1987) Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther 240:1–7 Battaglia SY, De Souza EB (1988) MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacol Biochem Behav 29:269–274 Kalant H (2001) The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs. CMAJ 165:7 Beitia G, Cobreros A, Sainz L et al (2000) Ecstasy-induced toxicity in rat liver. Liver 20:8–15 Gudelsky GA, Yamamoto BK (2003) Neuropharmacology and neurotoxicity of 3,4-methylenedioxymethamphetamine. Methods Mol Med 79:55–73 Zhou JF, Zhou YH, Zhang L et al (2003) 3,4-methylenedioxymethamphetamine (MDMA) abuse markedly inhibits acetylcholinesterase activity and induces severe oxidative damage and liperoxidative damage. Biomed Environ Sci 16:53–61 Cadet JL, Thiriet N, Jayanthi S (2001) Involvement of free radicals in MDMA-induced neurotoxicity in mice. Ann Med Interne 152:57–59 Colado MI, O´Shea E, Granados R et al (1997) In vivo evidence for free radical involvement in 5-HT following administration of MDMA (“ecstasy”) and p-chloroamphetamine but not the degeneration following fenfluramine. Br J Pharmacol 121:889–900 Gudelsky GA (1996) Effect of ascorbate and cysteine on the 3,4-methyl-enedioxymethamphetamine-induced depletion of brain serotonin. J Neural Transm 102:1397–1404 Shankaran M, Yamamoto BK, Gudelski GA (2001) Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and the behavioral and neurochemical consequences of the depletion of the brain. Synapse 40:55–64 Aguirre N, Barrionuevo M, Ramírez MJ et al (1999). Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity. Neuroreport 10:3675–3680 Clauwaert KM, Van Bocxlaer JF, De Letter EA et al (2000) Determination of the designer drugs 3, 4-methylenedioxymethamphetamine, 3,4-methylenedioxyethylamphetamine, and 3,4-methylenedioxyamphetamine with HPLC and fluorescence detection in whole blood, serum, vitreous humor, and urine. Clin Chem 46:1968–1977 Irurre J, Casas J, Ramos I et al (1993) Inhibition of rat liver microsomal lipid peroxidation elicited by 2,2-dimethylchromenes and chromans containing fluorinated moieties resistant to cytochrome P-450 metabolism. Bioorg Med Chem 1:219–225 Montoliu C, Llansola M, Sáez R et al (1999) Prevention of glutamate neurotoxicity in cultured neuronas by 3,4-dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran (CR-6), a sacvenger of nitric oxide. Biochem Pharmacol 58:255–261 Jimenez A, Jorda EG, Verdaguer E et al (2004) Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells. Toxicol Appl Pharmacol 196:223–234 Montiel-Duarte C, Ansorena E, Lopez-Zabalza MJ et al (2004) Role of reactive oxygen species, glutathione and NF-kappaB in apoptosis induced by 3,4-methylenedioxymethamphetamine (“Ecstasy”) on hepatic stellate cells. Biochem Pharmacol 67:1025–1033 Simantov R, Tauber M (1997) The abused drug MDMA (Ecstasy) induces programmed death of human serotonergic cells. FASEB J 11:141–146 Casas J, Gorchs G, Sanchez-Baeza F et al (1992) Inhibition of rat liver microsomal lipid peroxidation elicited by simple 2,2-dimethylchromenes and chromans structurally related to precocenes. J Agric Food Chem 40:585–590 Richard MJ, Guiraud P, Meo J et al (1992) High performance liquid chromatography separation of malondialdehyde thiobarbituric acid adduct in biological materials (plasma and human cell) using a comercially available reagent. J Chromatogr 577:9–18 Romero MJ, Bosch-Morell F, Romero B et al (1998) Serum malondialdehyde: possible use for the clinical management of chronic hepatitis C patients. Free Radical Biol Med 25:993–997 Lawrence RA, Parkhill LK, Burk RF (1978) Hepatic cytosolic non-selenium dependent glutathione peroxidase activity: its nature and the effect of selenium deficiency. J Nutr 108:981–987 Reed DJ, Babson JR, Beatty PW et al (1980) High-performance liquid chromatography analysis of nanomole levels of glutathione, glutathione disulfide, and related thiols and disulfides. Anal Biochem 106:55–62 Lowry OH, Rosebrough NJ, Farr AL et al (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275 Doly M, Droy-Lefaix MT, Braquet P (1992) Oxidative stress in diabetic retina. EXS62:299–307 Carvalho M, Milhazes N, Remiao F et al (2004) Hepatotoxicity of 3,4-methylenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates. Arch Toxicol 78:16–24 Colado MI, Camarero J, Mecham AO et al (2001) A study of the mechanisms involved in the neurotoxic action of 3,4-methylendioxymethamphetamine (MDMA, “ecstasy”) on dopamine neurones in mouse brains. Br J Pharmacol 134:1711–1723 Jayanthi S, Ladenheim B, Andrews AM et al (1999) Overexpression of human copper/zinc superoxide dismutase in transgenic mice attenuates oxidative stress caused by methylenedioxymethamphethamine (Ecstasy). Neuroscience 91:1379–1387 Camarero J, Sanchez V, O’Shea E et al (2002) Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine (‘ecstasy’)-induced dopamine release and free radical formation in the mouse striatum. J Neurochem 81:961–972 Gastinger MJ, Singh RS, Barber AJ (2006) Loss of Cholinergic and Dopaminergic Amacrine Cells in Streptozotocin-Diabetic Rat and Ins2Akita-Diabetic Mouse Retinas. Invest Ophthalmol Vis Sci 47:3143–3150 Takita H, Yoneya S, Gehlbach PL et al (2003) Retinal neuroprotection against ischemic injury mediated by intraocular gene transfer of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 44:4497–4504 Jacobsen LK, Mencl WE, Pugh KR et al (2004) Preliminary evidence of hippocampal dysfunction in adolescent MDMA (“ecstasy”) users: possible relationship to neurotoxic effects. Psychopharmacology 173:383–390 Huether G, Zhou D, Ruther E (1997) Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) and its congeners. J Neural Transm 104:771–794 Parrott AC (2001) Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research. Hum Psychopharmacol 16:557–577 Sanvicens N, Gómez-Vicente V, Masip I et al (2004) Oxidative stress-induced apoptosis in retinal photoreceptor cells is mediated by calpains and caspases and blocked by the oxygen radical scavenger CR-6. J Biol Chem 279:39268–39278